Successfully introducing innovative medical products and new therapy methods into the cost-sensitive healthcare market requires a targeted strategy. This must be measured against globalization and the growing networking of regional health systems.
There is only one mission for us:
To develop a successful strategy that aims to gain market access and appropriate remuneration for medical products and therapy methods. We keep an eye on the long-term optimization of regional and national reimbursement as well as short-term transitional financing and accompany the necessary processes from A to Z.